Unknown

Dataset Information

0

SVIP reduces IGFBP-2 expression and inhibits glioblastoma progression via stabilizing PTEN.


ABSTRACT: Glioblastoma (GBM) presents significant challenges due to its invasive nature and genetic heterogeneity. In this study, we investigated the impact of Small VCP/P97-Interacting Protein (SVIP) on GBM progression. Our results revealed elevated expression of Insulin-like Growth Factor Binding Protein 2 (IGFBP-2) and STIP1 homology and U-box containing protein 1 (STUB1), coupled with reduced SVIP levels in GBM samples. Notably, high IGFBP-2 expression correlated with poor prognosis. Mechanistically, SVIP competitively inhibited STUB1, selectively binding to VCP/p97, thereby reducing PTEN degradation. This SVIP-mediated regulation exerted influence on the PTEN/PI3K/AKT/mTOR pathway, leading to the suppression of GBM progression. Co-localization experiments demonstrated that SVIP hindered PTEN ubiquitination and degradation by outcompeting STUB1 for VCP/p97 binding. Moreover, SVIP overexpression resulted in reduced activation of AKT/mTOR signaling and facilitated autophagy. In vivo experiments using a GBM xenograft model substantiated the tumor-suppressive effects of SVIP, evident by suppressed tumor growth, decreased IGFBP-2 expression, and improved survival rates. Collectively, our findings underscore the functional significance of SVIP in GBM progression. By inhibiting STUB1 and stabilizing PTEN, SVIP modulates the expression of IGFBP-2 and attenuates the activation of the PI3K/AKT/mTOR pathway, thereby emerging as a promising therapeutic target for GBM treatment.

SUBMITTER: Wang Z 

PROVIDER: S-EPMC11322382 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

SVIP reduces IGFBP-2 expression and inhibits glioblastoma progression via stabilizing PTEN.

Wang Zixuan Z   Qiao Xiaolong X   Chen Yinan Y   Peng Nan N   Niu Chaoshi C   Wang Yang Y   Li Cong C   Hu Zengchun Z   Zhang Caihua C   Cheng Chuandong C  

Cell death discovery 20240813 1


Glioblastoma (GBM) presents significant challenges due to its invasive nature and genetic heterogeneity. In this study, we investigated the impact of Small VCP/P97-Interacting Protein (SVIP) on GBM progression. Our results revealed elevated expression of Insulin-like Growth Factor Binding Protein 2 (IGFBP-2) and STIP1 homology and U-box containing protein 1 (STUB1), coupled with reduced SVIP levels in GBM samples. Notably, high IGFBP-2 expression correlated with poor prognosis. Mechanistically,  ...[more]

Similar Datasets

| S-EPMC11387860 | biostudies-literature
| S-EPMC7782096 | biostudies-literature
| S-EPMC9134670 | biostudies-literature
| S-EPMC9583503 | biostudies-literature
| S-EPMC9974991 | biostudies-literature
| S-EPMC8895442 | biostudies-literature
| S-EPMC9724401 | biostudies-literature
| S-EPMC8430966 | biostudies-literature
| S-EPMC7343503 | biostudies-literature
| S-EPMC8490862 | biostudies-literature